AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.

GlobeNewswire
07/09

Aimei Health Technology Co., Ltd. Announces Termination of Business Combination Agreement

NEW YORK, July 08, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (NASDAQ: AFJK, AFJKU, AFJKR, the “Company”) announced today that it has terminated the Business Combination Agreement, dated as of June 19, 2024, as amended on June 6, 2025, with United Hydrogen Group Inc. (“United Hydrogen”) and the other parties thereto.

The Company delivered a notice of termination to United Hydrogen on July 7, 2026, pursuant to Section 9.1(b) of the Business Combination Agreement, effective immediately. The termination was triggered by the occurrence of the applicable outside date, as the closing of the proposed business combination was not consummated on or prior to such date.

Xie Junheng, Chief Executive Officer and Director of the Company, stated, “Although we were unable to complete the proposed business combination with United Hydrogen within the required timeframe, we remain confident in our ability to identify and execute a compelling transaction in the future. We thank the United Hydrogen team for their efforts and professionalism throughout the process.”

Contact:
Xie Junheng
Aimei Health Technology Co., Ltd
10 East 53rd Street, Suite 3001
New York, NY 10022
Email: Xiejunheng@aimeihealth.com


免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10